Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen

BACKGROUND: Triple negative breast cancer (TNBC) which is treated with taxane, adriamycin and cyclophosphamide (TAC) chemotherapy regimen show variation in treatment response. CYP1B1 4326 C>G polymorphism has been implicated in contributing to the differences in treatment response in various type...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Aziz, Ahmad Aizat, Md Salleh, Md Salzihan, Yahya, Maya Mazuwin, Zakaria, Andee Dzulkarnaen, Ankathil, Ravindran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325143/
https://www.ncbi.nlm.nih.gov/pubmed/33906328
http://dx.doi.org/10.31557/APJCP.2021.22.4.1319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325143/
https://www.ncbi.nlm.nih.gov/pubmed/33906328
http://dx.doi.org/10.31557/APJCP.2021.22.4.1319

Ejemplares similares